Ann R. Klee - May 22, 2025 Form 4 Insider Report for Sotera Health Co (SHC)

Role
Director
Signature
Matthew J. Klaben, Attorney-in-Fact
Stock symbol
SHC
Transactions as of
May 22, 2025
Transactions value $
$0
Form type
4
Date filed
5/27/2025, 04:41 PM
Previous filing
May 19, 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Klee Ann R. Director C/O SOTERA HEALTH COMPANY, 9100 SOUTH HILLS BLVD., SUITE 300, BROADVIEW HEIGHTS Matthew J. Klaben, Attorney-in-Fact 2025-05-27 0001796076

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SHC Common Stock, $0.01 par value per share ("Common Stock") Award $0 +19.1K +17.91% $0.00 126K May 22, 2025 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These securities consist of 19,132 restricted stock units ("RSUs") that were granted on May 22, 2025, pursuant to the terms of an RSU agreement under the Sotera Health Company 2020 Omnibus Incentive Plan. Each RSU represents the Reporting Person's right to receive one share of Common Stock, subject to vesting conditions. The RSUs will vest in full on the earlier of (i) the first anniversary of the date of grant, or (ii) the date immediately prior to the Issuer's next regular annual shareholders meeting, subject to the Reporting Person's continued service as a non-employee director of the Issuer through such date.
F2 Consist of 19,132 RSUs and 106,824 shares of Common Stock.

Remarks:

The Power of Attorney for Ms. Klee is filed as an exhibit to the Form 3 filed with the Securities and Exchange Commission on November 20, 2020, which is hereby incorporated by reference.